201 related articles for article (PubMed ID: 37759469)
21. FUS Mutant Human Motoneurons Display Altered Transcriptome and microRNA Pathways with Implications for ALS Pathogenesis.
De Santis R; Santini L; Colantoni A; Peruzzi G; de Turris V; Alfano V; Bozzoni I; Rosa A
Stem Cell Reports; 2017 Nov; 9(5):1450-1462. PubMed ID: 28988989
[TBL] [Abstract][Full Text] [Related]
22. Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons.
Shum C; Hedges EC; Allison J; Lee YB; Arias N; Cocks G; Chandran S; Ruepp MD; Shaw CE; Nishimura AL
Stem Cell Reports; 2024 Feb; 19(2):187-195. PubMed ID: 38242131
[TBL] [Abstract][Full Text] [Related]
23. PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport.
Tziortzouda P; Steyaert J; Scheveneels W; Sicart A; Stoklund Dittlau K; Barbosa Correia AM; Burg T; Pal A; Hermann A; Van Damme P; Moens TG; Van Den Bosch L
Acta Neuropathol; 2024 Feb; 147(1):41. PubMed ID: 38363426
[TBL] [Abstract][Full Text] [Related]
24. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
[TBL] [Abstract][Full Text] [Related]
25. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
[TBL] [Abstract][Full Text] [Related]
26. Quantitative proteomics identifies proteins that resist translational repression and become dysregulated in ALS-FUS.
Baron DM; Matheny T; Lin YC; Leszyk JD; Kenna K; Gall KV; Santos DP; Tischbein M; Funes S; Hayward LJ; Kiskinis E; Landers JE; Parker R; Shaffer SA; Bosco DA
Hum Mol Genet; 2019 Jul; 28(13):2143-2160. PubMed ID: 30806671
[TBL] [Abstract][Full Text] [Related]
27. 4-Aminopyridine Induced Activity Rescues Hypoexcitable Motor Neurons from Amyotrophic Lateral Sclerosis Patient-Derived Induced Pluripotent Stem Cells.
Naujock M; Stanslowsky N; Bufler S; Naumann M; Reinhardt P; Sterneckert J; Kefalakes E; Kassebaum C; Bursch F; Lojewski X; Storch A; Frickenhaus M; Boeckers TM; Putz S; Demestre M; Liebau S; Klingenstein M; Ludolph AC; Dengler R; Kim KS; Hermann A; Wegner F; Petri S
Stem Cells; 2016 Jun; 34(6):1563-75. PubMed ID: 26946488
[TBL] [Abstract][Full Text] [Related]
28. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS.
Xia R; Liu Y; Yang L; Gal J; Zhu H; Jia J
Mol Neurodegener; 2012 Mar; 7():10. PubMed ID: 22443542
[TBL] [Abstract][Full Text] [Related]
29. Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs.
Zhu Y; Burg T; Neyrinck K; Vervliet T; Nami F; Vervoort E; Ahuja K; Sassano ML; Chai YC; Tharkeshwar AK; De Smedt J; Hu H; Bultynck G; Agostinis P; Swinnen JV; Van Den Bosch L; da Costa RFM; Verfaillie C
Acta Neuropathol; 2024 Jan; 147(1):6. PubMed ID: 38170217
[TBL] [Abstract][Full Text] [Related]
30. Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization.
Casci I; Krishnamurthy K; Kour S; Tripathy V; Ramesh N; Anderson EN; Marrone L; Grant RA; Oliver S; Gochenaur L; Patel K; Sterneckert J; Gleixner AM; Donnelly CJ; Ruepp MD; Sini AM; Zuccaro E; Pennuto M; Pasinelli P; Pandey UB
Nat Commun; 2019 Dec; 10(1):5583. PubMed ID: 31811140
[TBL] [Abstract][Full Text] [Related]
31. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation.
Naumann M; Pal A; Goswami A; Lojewski X; Japtok J; Vehlow A; Naujock M; Günther R; Jin M; Stanslowsky N; Reinhardt P; Sterneckert J; Frickenhaus M; Pan-Montojo F; Storkebaum E; Poser I; Freischmidt A; Weishaupt JH; Holzmann K; Troost D; Ludolph AC; Boeckers TM; Liebau S; Petri S; Cordes N; Hyman AA; Wegner F; Grill SW; Weis J; Storch A; Hermann A
Nat Commun; 2018 Jan; 9(1):335. PubMed ID: 29362359
[TBL] [Abstract][Full Text] [Related]
32. Generation of two induced pluripotent stem cell lines with heterozygous and homozygous amyotrophic lateral sclerosis-causing mutation P525L (c.1574C > T) in FUS gene.
Akter M; Cui H; Abir Hosain M; Ding B
Stem Cell Res; 2023 Jun; 69():103103. PubMed ID: 37116345
[TBL] [Abstract][Full Text] [Related]
33. The ALS-Associated FUS (P525L) Variant Does Not Directly Interfere with Microtubule-Dependent Kinesin-1 Motility.
Seifert A; Drechsler H; Japtok J; Korten T; Diez S; Hermann A
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670886
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of β-catenin due to loss of miR-139 contributes to motor neuron death in amyotrophic lateral sclerosis.
Hawkins S; Namboori SC; Tariq A; Blaker C; Flaxman C; Dey NS; Henley P; Randall A; Rosa A; Stanton LW; Bhinge A
Stem Cell Reports; 2022 Jul; 17(7):1650-1665. PubMed ID: 35750046
[TBL] [Abstract][Full Text] [Related]
35. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
[TBL] [Abstract][Full Text] [Related]
36. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis.
Wang H; Guo W; Mitra J; Hegde PM; Vandoorne T; Eckelmann BJ; Mitra S; Tomkinson AE; Van Den Bosch L; Hegde ML
Nat Commun; 2018 Sep; 9(1):3683. PubMed ID: 30206235
[TBL] [Abstract][Full Text] [Related]
37. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.
Daigle JG; Krishnamurthy K; Ramesh N; Casci I; Monaghan J; McAvoy K; Godfrey EW; Daniel DC; Johnson EM; Monahan Z; Shewmaker F; Pasinelli P; Pandey UB
Acta Neuropathol; 2016 Apr; 131(4):605-20. PubMed ID: 26728149
[TBL] [Abstract][Full Text] [Related]
38. lncRNA Sequencing Reveals Neurodegeneration-Associated FUS Mutations Alter Transcriptional Landscape of iPS Cells That Persists in Motor Neurons.
Provasek VE; Kodavati M; Guo W; Wang H; Boldogh I; Van Den Bosch L; Britz G; Hegde ML
Cells; 2023 Oct; 12(20):. PubMed ID: 37887305
[TBL] [Abstract][Full Text] [Related]
39. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
[TBL] [Abstract][Full Text] [Related]
40. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
Wächter N; Storch A; Hermann A
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
